Epoch HealthStudy Finds ‘Significant Increase’ in Cancer Mortality After Mass Vaccination with 3rd COVID-19 Dose

Study Correlates Increased Cancer Mortality to Mass Vaccination with mRNA COVID-19 Boosters

Recent research published in Cureus has illuminated a concerning trend: a statistically significant rise in mortality rates from several types of cancer following the administration of third and subsequent doses of mRNA COVID-19 vaccines in Japan. The findings suggest potential mechanisms through which vaccines may influence cancer pathology, specifically through interactions with estrogen receptors and cellular immune responses.

Key Points:

• Researchers reported statistically significant increases in overall cancer mortality, particularly in estrogen-related cancers, following the mass vaccination campaign with the third dose of mRNA COVID-19 vaccines.
• During the initial pandemic year in Japan, no excess cancer deaths were observed; however, a subsequent increase in cancer mortality emerged coinciding with the vaccine rollout.
• Notable increases were observed in cancers sensitive to estrogen and estrogen receptor alpha, such as ovarian, leukemia, prostate, and breast cancers. Breast cancer, in particular, shifted from a deficit in mortality in 2020 to excess mortality in 2022.
• The study analyzed mortality data from 2010 through 2022, noting a shift towards excess mortality in 2021 that escalated in 2022, with all-cause mortality rising by 9.6% and all-cancer mortality by 2.1%.
• The majority of vaccines administered in Japan were mRNA-based, with Pfizer comprising 78% and Moderna 22%.
• Mechanisms suggested include the interaction of the vaccine’s spike protein with estrogen receptors and suppression of key immune responses, potentially affecting cancer progression.
• Long-term presence of vaccine-induced spike proteins and lipid nanoparticles in the body was noted as a potential contributor to increased cancer susceptibility.
• Concerns were raised regarding thrombogenic effects of mRNA vaccines and lipid nanoparticles, which could exacerbate risks in individuals with cancer.

“I have long suspected a cancer link to the vaccines just based on the science of immunology… What I think is happening, broadly speaking, is that the vaccine is causing impairment of the innate immune response, which leads to an increased susceptibility to any infection, increased autoimmune disease, and accelerated cancer progression.”
– Stephanie Seneff, a senior research scientist at MIT

More on Vaccines/Immunization